HS
MRTX

Haafor (Singapore)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Haafor (Singapore)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$202K Buy
+919
New +$199K 0.38% 137

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Haafor (Singapore)'s MRTX Position: Q4 2020 in Review

Haafor (Singapore) opened a new position in Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2020: 919 shares worth $202K. The stake represents 0.38% of the portfolio and ranks #137 among its holdings.

284 funds tracked by Wall St. Rank hold MRTX as of Q4 2020.

  • Haafor (Singapore) held 919 shares of Mirati Therapeutics, Inc. Common Stock worth $202K as of Q4 2020.
  • Mirati Therapeutics, Inc. Common Stock was a new Haafor (Singapore) position in Q4 2020.
  • Mirati Therapeutics, Inc. Common Stock made up 0.38% of Haafor (Singapore)'s portfolio in Q4 2020, its #137 holding.
  • 284 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.